Clearstead Advisors, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Clearstead Advisors, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$16,426
+30.4%
300
+100.0%
0.00%
-100.0%
Q2 2023$12,597
+10.9%
1500.0%0.00%0.0%
Q1 2023$11,360
+22.7%
1500.0%0.00%0.0%
Q4 2022$9,258
+54.3%
1500.0%0.00%0.0%
Q3 2022$6,000
+20.0%
1500.0%0.00%
Q2 2022$5,000
+25.0%
1500.0%0.00%
Q1 2022$4,000
+33.3%
1500.0%0.00%
Q4 2021$3,000
-40.0%
1500.0%0.00%
Q3 2021$5,0000.0%1500.0%0.00%
Q2 2021$5,000
-16.7%
1500.0%0.00%
Q1 2021$6,0001500.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sandhill Capital Partners LLC 1,805,518$34,594,0002.69%
Millrace Asset Group, Inc. 83,723$1,604,0000.94%
Bullseye Asset Management LLC 117,031$2,218,0000.88%
Taylor Wealth Management Partners 72,782$1,395,0000.49%
MOODY ALDRICH PARTNERS LLC 166,078$3,182,0000.44%
HARBOURVEST PARTNERS LLC 116,123$2,225,0000.28%
NEXT CENTURY GROWTH INVESTORS LLC 161,819$3,100,0000.28%
EMERALD MUTUAL FUND ADVISERS TRUST 300,492$5,757,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 82,255$1,576,0000.18%
EMERALD ADVISERS, LLC 244,816$4,691,0000.17%
View complete list of TRANSMEDICS GROUP INC shareholders